Aeglea BioTherapeutics, Inc. (AGLE)
(Delayed Data from NSDQ)
$6.96 USD
+0.24 (3.57%)
Updated May 3, 2019 04:00 PM ET
After-Market: $6.94 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For AGLE
-
Aeglea: Q3 Earnings Snapshot
-
Aeglea BioTherapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
-
Aeglea: Q2 Earnings Snapshot
-
Aeglea BioTherapeutics Reports Second Quarter 2023 Financial Results
-
Aeglea Biotherapeutics (AGLE) Reports Q1 Loss, Tops Revenue Estimates
-
Aeglea: Q1 Earnings Snapshot
-
Aeglea BioTherapeutics Reports First Quarter 2023 Financial Results
-
Aeglea Biotherapeutics (AGLE) Reports Q4 Loss, Lags Revenue Estimates
-
Aeglea BioTherapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Program Updates
-
Aeglea Biotherapeutics (AGLE) Reports Q3 Loss, Misses Revenue Estimates
-
Aeglea: Q3 Earnings Snapshot
-
Aeglea BioTherapeutics Reports Third Quarter 2022 Financial Results and Provides Program Updates
-
Aeglea Biotherapeutics (AGLE) Reports Q2 Loss, Lags Revenue Estimates
-
Aeglea: Q2 Earnings Snapshot
-
Aeglea BioTherapeutics Reports Second Quarter 2022 Financial Results and Provides Program Updates
-
Aeglea Biotherapeutics (AGLE) Reports Q1 Loss, Lags Revenue Estimates
-
Aeglea Biotherapeutics (AGLE) Reports Q4 Loss, Tops Revenue Estimates
-
Aeglea Biotherapeutics (AGLE) Reports Q3 Loss, Tops Revenue Estimates
-
Aeglea Biotherapeutics (AGLE) Reports Q2 Loss, Tops Revenue Estimates